Meds & supplements › Allopurinol
Medicine · Xanthine Oxidase Inhibitor
Allopurinol tablets are indicated for: The management of adults with signs and symptoms of primary or secondary gout (acute attacks, tophi, joint destruction, uric acid lithiasis
Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗
Allopurinol tablets are indicated for:
Limitations of Use
Allopurinol tablets are not recommended for the treatment of asymptomatic hyperuricemia.
The following clinically significant adverse reactions are described elsewhere in the labeling:
The following adverse reactions associated with the use of allopurinol were identified in literature, unpublished clinical trials or postmarketing reports. Because some of these reactions were reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. The most frequent adverse reaction to allopurinol is skin rash.
Most Common Adverse Reactions (≥ 1%)
Gastrointestinal: Diarrhea, nausea, alkaline phosphatase increase, AST/ALT increase.
Metabolic and Nutritional: Acute attacks of gout. Skin and Appendages: Rash, maculopapular rash.
Less Common Adverse Reactions (< 1%)
Body As a Whole: Ecchymosis, fever, headache, malaise.
Cardiovascular: Necrotizing angiitis, vasculitis, pericarditis, peripheral vascular disease, thrombophlebitis, bradycardia, vasodilation.
Gastrointestinal: Hepatic necrosis, granulomatous hepatitis, hepatomegaly, hyperbilirubinemia, cholestatic jaundice, vomiting, intermittent abdominal pain, gastritis, dyspepsia, hemorrhagic pancreatitis, gastrointestinal bleeding, stomatitis, salivary gland swelling, hyperlipidemia, tongue edema, anorexia.
Hemic and Lymphatic: Thrombocytopenia, eosinophilia, leukocytosis, leukopenia, aplastic anemia, agranulocytosis, eosinophilic fibrohistiocytic lesion of bone marrow, pancytopenia, prothrombin decrease, anemia, hemolytic anemia, reticulocytosis, lymphadenopathy, lymphocytosis.
Musculoskeletal: Myopathy, arthralgias, myalgia.
Nervous: Peripheral neuropathy, neuritis, paresthesia, somnolence, optic neuritis, confusion, dizziness, vertigo, foot drop, decrease in libido, depression, amnesia, tinnitus, asthenia, insomnia.
Respiratory: Epistaxis, bronchospasm, asthma, pharyngitis, rhinitis.
Skin and Appendages: Erythema multiforme exudativum (Stevens-Johnson syndrome), toxic epidermal necrolysis (Lyell's syndrome), hypersensitivity vasculitis, purpura, vesicular bullous dermatitis, exfoliative dermatitis, eczematoid dermatitis, pruritus, urticaria, alopecia, onycholysis, lichen planus, furunculosis, facial edema, sweating, skin edema.
Special Senses: Taste loss/perversion, cataracts, macular retinitis, iritis, conjunctivitis, amblyopia.
Urogenital: Renal failure, uremia, nephritis, impotence, primary hematuria, albuminuria.
Endocrine: Infertility (male), hypercalcemia, gynecomastia (male).
Allopurinol tablets are contraindicated in patients with a history of hypersensitivity reaction to allopurinol or to any of the ingredients of allopurinol tablets.
sofidex [Internet]. Daloreum; c2026. Allopurinol; [reviewed 2026 Aug 2; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/allopurinol
sofidex. (2026, August 2). Allopurinol. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/allopurinol
Allopurinol. sofidex. Reviewed August 2, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/allopurinol
The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.